One of them, an estrogen-receptor positive breast carcinoma with a Chr22q11 amplification (ST3632), as revealed by FISH, was found to be sensitive to the AZD2811 nanoparticles (Fig. 9G). This evidence concerns the gene ESR1 and breast carcinoma.